Brief: Cereno Scientific Gets Patent Approval In Australia
March 7 (Reuters) - Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC RECEIVES PATENT APPROVAL IN AUSTRALIA
FOR USE
OF DRUG CANDIDATE CS1
* AUSTRALIAN PATENT WILL BE VALID THROUGH 2032, WITH
POSSIBILITY
OF A PATENT EXTENSION OF AN ADDITIONAL FIVE YEAR MAXIMUM.
Source text for Eikon: ID:nWkr3Lmm6q
Further company coverage: CRNOSb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln